Elliott Management founder Paul Singer. His firm is currently targeting GSK and SSE
(Picture: REUTERS)Activist investors used to be a uniquely American phenomenon: silverbacks like Carl Icahn and Paul Singer made billions stalking the boardrooms of Wall Street, noisily pushing for change.
But last year saw the highest number of activist campaigns targeting London-listed companies in half a decade. 2022 is off to an even stronger start: companies worth a collective $500 billion are in the crosshairs, according to Bloomberg.
